FAQ/Help |
Calendar |
Search |
Today's Posts |
|
![]() |
#1 | |||
|
||||
Member
|
NIH has granted $4 million to the company UC Davis founded to pursue this SEH inhibitor approach to treating neuropathic pain.
![]() http://www.centralvalleybusinesstime.../001/?ID=29766 "Now known as EC5026, the compound is “a potent, orally active and a non-narcotic analgesic that does not adversely affect the brain, gastrointestinal tract, or cardiovascular system,” says Alan Buckpitt, the company's vice president of pharmacology and emeritus professor of molecular biosciences at the UC Davis School of Veterinary Medicine. “The compound effectively treats pain in preclinical models at low oral doses with no apparent adverse or addictive effects. Preclinical studies demonstrate efficacy that exceeds current therapies for diabetic neuropathy.”" ________ |
|||
![]() |
![]() |
![]() |
#2 | ||
|
|||
Member
|
Quote:
Cliffman ![]() |
||
![]() |
![]() |
![]() |
#3 | |||
|
||||
Wisest Elder Ever
|
The mention of "early" clinical trials suggests that the process is just beginning. That means 5+years or more.
__________________
All truths are easy to understand once they are discovered; the point is to discover them.-- Galileo Galilei ************************************ . Weezie looking at petunias 8.25.2017 **************************** These forums are for mutual support and information sharing only. The forums are not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Always consult your doctor before trying anything you read here.
|
|||
![]() |
![]() |
"Thanks for this!" says: | Cliffman (01-14-2016) |
Reply |
|
|
![]() |
||||
Thread | Forum | |||
Neuropathic pain study: Scripps Research Institute | Peripheral Neuropathy | |||
Ms & neuropathic pain | Chronic Pain | |||
Neuropathic Pain | New Member Introductions | |||
Neuropathic Pain | Peripheral Neuropathy | |||
Neuropathic Pain | New Member Introductions |